Lexicon Pharmaceuticals
LXRX
#6255
Rank
โ‚น97.87 B
Marketcap
โ‚น220.35
Share price
-1.28%
Change (1 day)
136.04%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -โ‚น6.29

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น6.68. In 2025 the company made an earnings per share (EPS) of -โ‚น13.35 an increase over its 2024 EPS that were of -โ‚น61.05.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น6.29-52.92%
2025-โ‚น13.35-78.13%
2024-โ‚น61.05-20%
2023-โ‚น76.3131.15%
2022-โ‚น58.19-0%
2021-โ‚น58.1910.91%
2020-โ‚น52.46-145.08%
2019โ‚น116.38-206.09%
2018-โ‚น109.70-5.74%
2017-โ‚น116.38-10.95%
2016-โ‚น130.682640%
2015-โ‚น4.77-96.34%
2014-โ‚น130.17-2.53%
2013-โ‚น133.55-9.09%
2012-โ‚น146.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,738-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น527.51-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4,057-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น582.83 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น747.86-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.91-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น71.54 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น133.55-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1,56,130 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA